Eng, J. W., Mace, T. A., Sharma, R., Twum, D. Y. F., Peng, P., Gibbs, J. F., . . . Hylander, B. L. (2016). Pancreatic cancer stem cells in patient pancreatic xenografts are sensitive to drozitumab, an agonistic antibody against DR5. J Immunother Cancer.

Eng, Jason W.-L., et al. "Pancreatic Cancer Stem Cells in Patient Pancreatic Xenografts Are Sensitive to Drozitumab, an Agonistic Antibody against DR5." J Immunother Cancer 2016.

Eng, Jason W.-L., et al. "Pancreatic Cancer Stem Cells in Patient Pancreatic Xenografts Are Sensitive to Drozitumab, an Agonistic Antibody against DR5." J Immunother Cancer 2016.